<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Advisory Committee; Oncologic Drugs Advisory Committee, Renewal</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Advisory Committee; Oncologic Drugs Advisory Committee, Renewal</h1>
    <p class="timestamp">Published: 2016-09-08 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the renewal of the Oncologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Oncologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until September 1, 2018.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-21550</p>
    <p><strong>Publication Date:</strong> 2016-09-08</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/09/08/2016-21550/advisory-committee-oncologic-drugs-advisory-committee-renewal">https://www.federalregister.gov/documents/2016/09/08/2016-21550/advisory-committee-oncologic-drugs-advisory-committee-renewal</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-21550</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
